Safety and efficacy of cognitive training plus epigallocatechin-3-gallate in young adults with Down's syndrome (TESDAD): A double-blind, randomised, placebo-controlled, phase 2 trial

TESDAD study group

Research output: Contribution to journal › Article › peer-review

203 Scopus citations

Fingerprint

Dive into the research topics of 'Safety and efficacy of cognitive training plus epigallocatechin-3-gallate in young adults with Down's syndrome (TESDAD): A double-blind, randomised, placebo-controlled, phase 2 trial'. Together they form a unique fingerprint.